Further studies, determining the association of RNFL thickness with WMH and other biomarkers of AD, e.g., hippocampus volume, CSF Aβ and/or Tau, are warranted to determine the underlying mechanisms of our clinical observation. Here, MAPT is linked to Alzheimer disease.